Oral Typhoid Vaccine Market Size and Trends

The oral typhoid vaccine market size is expected to reach US$ 285.6 Mn by 2030, from US$ 126.8 Mn in 2023, at a compound annual growth rate (CAGR) of 12.3% during the forecast period.

The oral typhoid vaccine market is characterized by the production and distribution of vaccines that are designed to prevent typhoid fever through oral administration. These vaccines are considered effective and convenient in providing immunity against the disease, particularly in regions with a high incidence of typhoid. The key market players include pharmaceutical companies and vaccine manufacturers who develop and distribute these vaccines to healthcare facilities, travel clinics, and vaccination programs. The factors which are driving the market growth include the rising awareness of typhoid prevention, increased travel to typhoid-endemic regions, and government initiatives to control the disease. However, challenges such as vaccine availability, affordability, and accessibility in low-income regions remain significant concerns within the oral typhoid vaccine market. Continuous research and development (R&D) efforts are aimed at improving vaccine efficacy and expanding its global reach.

Oral Typhoid Vaccine Market Trends:

Government vaccination programs: Many governments are implementing mass vaccination campaigns to control typhoid outbreaks, thus driving the adoption of oral typhoid vaccines.
Growing demand for needle-free vaccines: There is a growing demand for needle-free vaccines. This is due to the fact that needle-free vaccines are more convenient and less painful than traditional vaccines. The growing demand for needle-free vaccines is expected to create new trends in the oral typhoid vaccine market.